Your browser doesn't support javascript.
loading
Values and diagnostic accuracy of sensory nerve action potentials in control participants and participants with diabetes with and without clinical diabetic neuropathy, based on neuropathy scale measurements.
Abuzinadah, Ahmad R; Alrawaili, Moafaq S; Alshareef, Aysha A; Alkully, Hussien S; Milyani, Haneen; Alamri, Bashayr; Alshora, Weam; Bamaga, Ahmed K.
Afiliação
  • Abuzinadah AR; Department of Neurology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alrawaili MS; Neuromuscular Medicine Unit, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alshareef AA; Department of Neurology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alkully HS; Neuromuscular Medicine Unit, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Milyani H; Department of Neurology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alamri B; Neuromuscular Medicine Unit, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alshora W; Neurology Section, Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
  • Bamaga AK; Neurophysiology Department, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
Brain Behav ; 14(2): e3423, 2024 02.
Article em En | MEDLINE | ID: mdl-38351301
ABSTRACT

BACKGROUND:

The assessment of the normative values of sensory nerve action potentials (SNAP) and their diagnostic accuracies using validated neuropathy-assessment tools to classify participants into groups with and without neuropathy was not previously described in the literature.

METHODS:

The Utah Early Neuropathy Scale (UENS), Michigan neuropathy-screening instrument, and nerve conduction data were collected prospectively. We described and compared the values of the sural, superficial peroneal sensory (SPS), and superficial radial SNAP amplitude in different age groups for three groups. Group 1 (G1)-control participants (UENS <5), group 2 (G2)-participants with diabetes without clinical diabetic neuropathy (UENS <5), and group 3 (G3)-participants with clinical diabetic neuropathy (UENS ≥5). We also described the diagnostic accuracy of single-nerve amplitude and a combined sensory polyneuropathy index (CSPNI) that consists of four total points (one point for each of the following nerves if their amplitude was <25% lower limit of normal right sural, left sural, right SPS, and left SPS potentials).

RESULTS:

We assessed 135 participants, including 41, 37, and 57 participants in G1, G2, and G3, respectively, with age median (interquartile ranges) of 51 (45-56), 47 (38-56), and 54 (51-61) years, respectively, whereas 19 (46.3%), 18 (48.7%), and 32 (56.14%) of them were males, respectively. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) scores were 68.4%, 92.3%, 86.7%, and 80% for the sural amplitude; 86%, 58.3%, 62%, and 84% for the SPS amplitude; 66.7%, 94.4%, 90.5%, and 78.2% for the CSPNI of 3; and 54.4%, 98.6%, 96.9%, and 73.2% for the CSPNI of 4, respectively.

CONCLUSION:

Sural nerve had a high specificity for neuropathy; however, the CSPNI had the highest specificity and PPV, whereas the SPS had the highest sensitivity and NPV.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polineuropatias / Diabetes Mellitus / Neuropatias Diabéticas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polineuropatias / Diabetes Mellitus / Neuropatias Diabéticas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article